Trial result ·
Early Metformin Initiation and Glycemic Outcomes in Gestational Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This study looked again at data from an earlier drug trial. The trial took place at 2 hospitals in Ireland. It included people with gestational diabetes. By chance, each person got metformin or a dummy pill. Neither the people nor the staff knew who got which. Both groups also got their usual care. The team used a different way to weigh several blood sugar results together.
What they found
In all, 526 of 535 pregnancies had data for the main results. Of these, 264 got metformin and 262 got the dummy pill. Overall, metformin did better than the dummy pill. The results looked at the need for insulin and high fasting blood sugar. Fasting sugar was checked at weeks 32 and 38 of pregnancy. The largest gap was in the need to start insulin. The results held up across several ways of scoring them.
What it means for patients
The authors say early metformin came out ahead of the dummy pill. This was true for insulin need and fasting blood sugar. They say this method gives a clearer view of combined results. They add it may help plan how future trials measure results.
Why it is not certain yet
This was a second look at data from a trial already done. The original trial was not set up mainly for this analysis. The trial was run at 2 hospitals, both in Ireland. The abstract does not report side effects or how the babies did.
Source
Early Metformin Initiation and Glycemic Outcomes in Gestational Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
PubMed · PMID 42975901We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Gestational diabetes publications